ITGA5 and infection: The specific EVs surface marker characterization (CD49e, CD209, CD69, CD142, and CD20) allowed for the drawing of a defined EV signature, useful to discriminate between patients negative for SARS-CoV-2 who experienced infection symptoms and those with positive clinical status of the infection.